CYANOTECH CORP (CYAN)

↓ Download CSV

CIK 0000768408 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

In fiscal 2025, CYANOTECH CORP reported revenue of $24.21M, up 5.0% from the prior year. The company ran a net loss, with a net margin of -13.2% and a gross margin of 28.4%. It held $23.49M in total assets against $14.61M in total liabilities.

Key ratios (FY2025)

28.4%
Gross margin
-10.4%
Operating margin
-13.2%
Net margin
-36.1%
Return on equity
+5.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$24.21M$23.07M$23.18M$35.97M$32.34M$31.90M$30.20M$34.12M$32.04M
Cost of Revenue$17.34M$17.13M$15.92M$22.40M$21.23M$19.20M$19.74M$20.74M$19.82M$19.97M
Gross Profit$6.88M$5.95M$7.26M$13.57M$11.12M$12.70M$10.47M$13.37M$12.22M$11.87M
Operating Income-$2.51M-$4.59M-$2.92M$2.57M$84.0K$1.05M-$3.00M$1.41M-$682.0K-$785.0K
Net Income-$3.20M-$5.27M-$3.44M$2.15M$920.0K$387.0K-$3.60M$1.02M-$1.22M-$4.39M
EPS (Diluted)$-0.45$-0.81$-0.55$0.35$0.15$0.06$-0.62$0.18$-0.21$-0.79
Total Assets$23.49M$25.11M$29.73M$32.05M$30.88M$31.79M$29.63M$29.71M$29.16M$31.15M
Total Liabilities$14.61M$13.30M$13.38M$12.56M$13.84M$15.94M$14.72M$11.60M$12.55M$13.32M
Shareholders' Equity$8.88M$11.81M$16.35M$19.49M$17.04M$15.85M$14.91M$18.11M$16.61M$17.83M
Cash & Equivalents$257.0K$707.0K$974.0K$2.59M$3.77M$2.42M$840.0K$1.33M$1.41M$1.24M
Operating Cash Flow-$1.19M-$455.0K-$2.10M$2.38M$2.40M$1.24M-$847.0K$1.49M$1.22M$745.0K
Capital Expenditures$431.0K$1.00M$847.0K$4.30M
Shares Outstanding7.20M6.95M6.27M6.20M6.12M6.01M5.88M5.77M5.69M5.60M